Dustin Samples

Articles by Dustin Samples

Dustin SamplesTreatment | May 22, 2023
The results did not support anecdotal reports that the essential oil relieves cancer-related symptoms.
Read More
Dustin SamplesGVHD | May 17, 2023
In one murine study, donor T cells appeared to maintain a progenitor-like population in GVHD-affected tissue.
Dustin SamplesGVHD | May 17, 2023
Erythema body surface area kept its total prognostic information on NRM and OS longer than the NIH scoring system.
Dustin SamplesPatient Voice | May 11, 2023
The GVHD Alliance is thorough and logical in its presentation of material, and it offers a search by symptom option.
Dustin SamplesConferences | May 2, 2023
Patients who remained MRD-negative for ≥12 months had better duration of response and progression-free survival.
Dustin SamplesTreatment | April 28, 2023
Linda Buck led a information session on sacituzumab govitecan-hziy at ONS 2023.
Dustin SamplesConferences | April 27, 2023
Accelerated approvals will no longer be granted based on overall response rates in single-arm trials.
Dustin SamplesGU Cancer | April 24, 2023
The novel monoclonal antibody targeted B7-H3 with high success and low incidence of adverse events.
Dustin SamplesGVHD | April 19, 2023
A single-center study demonstrated good results with the trio of PT-Cy, tacrolimus, and low-dose anti-thymocyte globulin.
Dustin SamplesGVHD | April 19, 2023
Exosomes, T regulatory cells, and myeloid-derived-suppressor-cells could be the future of GVHD prevention.
Dustin SamplesPatient Voice | April 13, 2023
It might seem counterintuitive, but the “less is more” approach may be best when providing cancer resources.
Dustin SamplesPatient Voice | April 13, 2023
Though studies on the subject are plentiful, there is a lack of evidence supporting exercise as an effective pain mitigator.
Dustin SamplesPatient Voice | April 13, 2023
Despite research suggesting deterioration in HCP-patient relationships at EOL, patients in one study did not feel abandoned.
Dustin SamplesPatient Voice | April 13, 2023
Do the physiological effects of stress correlate with increased depression in adult cancer survivors?
Dustin SamplesConferences | April 6, 2023
The approved dosing schedule for venetoclax is time-limited, but how many patients follow the schedule?
Dustin SamplesConferences | April 6, 2023
Though rare, CLL and CML sometimes occur sequentially or concurrently. But what is the mechanism behind the relationship?
Dustin SamplesConferences | April 6, 2023
In a currently enrolling trial, patients with CLL and NMSC will receive experimental treatment with nicotinamide.
Dustin SamplesConferences | April 6, 2023
Deborah Stephens, DO, presented the recommendations and algorithms for first-, second-, and third-line CLL/SLL therapy.
Dustin SamplesGVHD | March 29, 2023
Certain species were predictive of not only the occurrence of GVHD, but also the severity.
Dustin SamplesGVHD | March 29, 2023
Pruritus is considered a mild adverse event, but does it negatively affect quality of life?